Published

Prevalence of Use of Psilocybin and MDMA in Multiple US Cities

No abstract is available for this record.

Open source BibTeX RIS

Bibliographic context

Journal: Drug and Alcohol Dependence
Date: 2025-01-31
Source: OpenAlex
DOI: 10.1016/j.drugalcdep.2024.112186
PubMed: Unavailable

Authors

Tamara A. Millay Nae Won Anna Wang Joseph J. Palamar Linda B. Cottler

Watch author

Topics and keywords

psilocybin Toxicity Other Psilocybin MDMA Hallucinogen Psychology Psychiatry Medicine Psychedelics and Drug Studies Cannabis and Cannabinoid Research Forensic Toxicology and Drug Analysis

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Prevalence of Use of Psilocybin and MDMA in Multiple US Cities2025-01-31

Related papers

Acute Effects of 4-Bromo-2,5-Dimethoxyphenethylamine (2C-B) Compared With Psilocybin and MDMA in Healthy ParticipantsBiological Psychiatry · 2026-04-24 Prevalence and Correlates of Past-Year Psilocybin Use in the United StatesAmerican Journal of Psychiatry · 2026-04-21 MDMA and Psilocybin Regulate Oligodendrocyte-Lineage Cell Numbers and Anxiety-Like Behaviors in a Rat Model of FearBiological Psychiatry · 2026-01-31 Sudden Loss of Consciousness Following Psilocybin IngestionAmerican Journal of Psychiatry · 2025-11-30 Psilocybin Outside the ClinicJAMA Psychiatry · 2025-11-04 Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal IdeationThe Journal of Clinical Psychiatry · 2026-05-11 Case Report: Repeated low doses of psilocybin reduce perceived symptom severity but fail to restore cognitive flexibility in a case of severe obsessive-compulsive disorder: an observational case study of identical twinsFrontiers in Psychiatry · 2026-04-20 Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical ImplicationsFOCUS The Journal of Lifelong Learning in Psychiatry · 2026-03-31